NEVASH 2022 Introduces Compelling Viewpoints for Treating Valve Disease

NEVASH 2022 Introduces Compelling Viewpoints for Treating Valve Disease

Join the debate as Dr. Nikolaos Kakouros, MBBS, MD(Res), PhD, FRCP, FACC, FSCAI, Director, Structural Heart Disease (SHD) Program, UMASS Medical School and Dr. Michael N. Young, MD, RPVI, FSCAI, Director, Structural Heart Disease Program, Dartmouth-Hitchcock Medical Center share their respective academic approaches to TAVR.?

NEVASH Course Director, Dr. Ashequl M. Islam, MD, MPH, along with his co-directors, has curated this 2-day event with the goal of delivering positive patient outcomes, beginning with understanding the disease state specific to each patient and creating a treatment plan unique to the patient’s needs. This symposium focuses on the importance of assessing patient needs and risk factors that may lead to potential complications during surgical treatment. Each session addresses challenges in valve disease, including methods for diagnosing mitral valve disease, repair techniques, and more.?

“Great meeting. A very comprehensive and practical overview of the new technology and state of the art in heart valve space.” Serguei Melnitchouk, MD, MPH
“Fantastic speakers and content. Wonderful to be together with colleagues again.” Robin Childress, PA-C

Save your seat for the debate and all of the exciting sessions at NEVASH 2022. Special breakout sessions are planned for Fellows and Nurses. Join us in Boston and take away tips and tricks you can implement into your practice immediately. Register Today!

要查看或添加评论,请登录

CineMed的更多文章

社区洞察

其他会员也浏览了